A Rapid Fluorescence Quenching Assay for Total Levothyroxine Quantification in Pharmaceutical and Supratherapeutic Serum Samples
Open Access
- 15 September 2025
- journal article
- research article
- Published by Springer Nature in Journal of Fluorescence
- Vol. 35 (12) , 13619-13634
Abstract
A rapid, cost-effective spectrofluorometric method was developed for levothyroxine (T4) detection using fluorescein isothiocyanate (FITC) as a fluorescent probe. The method exploits FITC fluorescence quenching by T4 in Tris/phosphate buffers (pH 7.4),with linear ranges of 8.00 × 10⁻⁶ – 6.40 × 10⁻⁵ mol/L and detection limits of 9.60 × 10⁻⁶ mol/L (Tris) and 8.80 × 10⁻⁶ mol/L (phosphate). Stern-Volmer analysis confirmed dynamic quenching dominated by electrostatic interactions. The method demonstrated 102–104% recovery in spiked human serum and minimal interference from common drugs (Ciprofloxacin, Alendronate) and ions (Fe³⁺, Al³⁺). Compared to HPLC and kinetic methods, this approach offers simplicity, speed, and accessibility for routine pharmaceutical/clinical analysis.Keywords
Funding Information
- Arish University
This publication has 21 references indexed in Scilit:
- Exploitation of erythrosine B as a fluorometric marker for lurasidone determination through electrostatic attraction; application to content uniformity testLuminescence, 2024
- Versatile applications of a spectrofluorimetric approach based on photo-induced electron transfer blocking of LurasidoneJournal of Molecular Liquids, 2023
- First case of genetically confirmed CLN3 disease in Chinese with cDNA sequencing revealing pathogenicity of a novel splice site variantClinica Chimica Acta, 2018
- Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticlesInternational Journal of Pharmaceutics, 2010
- Conditions and drugs interfering with thyroxine absorptionBest Practice & Research Clinical Endocrinology & Metabolism, 2009
- Quantitative and qualitative evaluation of plasma and urine α1-microglobulin in healthy donors and patients with different haemolytic disorders and haemochromatosisClinica Chimica Acta, 2007
- New Medications Which Decrease Levothyroxine AbsorptionThyroid®, 2007
- Simultaneous presence of static and dynamic component in the fluorescence quenching for substituted naphthalene—CCl4 systemJournal of Luminescence, 1995
- Localization of Human Thyroxine AbsorptionThyroid®, 1991
- Thyroid Hormone and the GutEndocrine Research, 1988